Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Perspectives

  3. The right diagnosis at the right time

Point-of-care testing

The right diagnosis at the right time

The increasing use of high-sensitivity cardiac troponin testing is helping heart attack patients get the care they need more quickly while also reducing pressure on emergency departments.

5min
Sameh Fahmy
Published on 28. September 2021

In many cases, the chest pain, shortness of breath and nausea strike suddenly and dramatically. Other times, patients experience a milder feeling of pressure or fullness in the chest that comes and goes. 

Causes of chest pain

Emergency patient waiting for diagnosis.
A quick diagnosis in a threatening situation can significantly shorten the time between hope and fear for a patient.

A visit to the emergency department

Waiting for troponin I test results
When ruling out a potential myocardial infarction, every minute spent waiting on test results comes at a cost.

Faster, more convenient cardiac troponin testing

The handheld Atellica® VTLi Patient-side Immunoassay Analyzer is used for fast and more convenient cardiac troponin testing.
High-sensitivity testing with the Atellica® VTLi Patient-side Immunoassay Analyzer is done right at the point of care.

“Time is muscle”

Leading causes of death globally

A major global healthcare issue

Global incidence of cardiovascular disease
By Sameh Fahmy
Sameh Fahmy, MS, is an award-winning freelance medical and technology journalist based in Athens, Georgia, USA.

Discover more

Siemens Healthineers facilitates access to MRI with cost-effective whole-body scanner

Siemens Healthineers expands production site in Rudolstadt, Germany and creates new jobs

  1. 1 Atellica VTLi Patient-side Immunoassay Analyzer is not available for sale in the U.S.A. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.

  2. [1] Hsia et. al, JAMA Intern Med. 2016;176(7):1029-1032

  3. [2] Siemens Healthineers Video: Rapid Diagnostic Algorithms for Acute Coronary Syndromes

  4. [3] Goodacre et. al., Heart. 2005 Feb; 91(2): 229–230

  5. [4] Park et. al., Cardiovascular Research, Volume 113, Issue 14, December 2017, Pages 1708–1718

  6. [5] Eggers et. al, European Heart Journal, Volume 37, Issue 30, 7 August 2016, Pages 2417–2424

  7. [6] Shah et. al, Lancet. 2015 Dec 19;386(10012):2481-8

  8. [7] Wu et. al, Clinical Chemistry, Volume 64, Issue 4, 1 April 2018, Pages 645–655

  9. [8] Siemens Healthineers Video: New IFCC Task Force on Cardiac Biomarker Guidelines; Impact on Patient Care

  10. [9] Siemens Healthineers website: A vital leap forward in cardiac testing

  11. [10] World Health Organization: Cardiovascular Disease Fact Sheet (accessed 8/24/2021)

  12. [11] Kotseva et. al, Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157

  13. [12] Morley et. al, PLoS One. 2018; 13(8): e0203316

  14. [13] Khan et. al, Cureus. 2020 Jul 23;12(7): e9349

  15. [14] Select Science Webinar: High-sensitivity point-of-care cardiac troponin: Novel whole-blood testing at last (accessed 9/20/2021)

  16. Fred S. Apple, PhD, receives financial support from Siemens Healthineers for collaborations.